FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

L F A G Massuger

Research Profile

Disorders

Chemicals & Drugs

Living Beings

Concepts & Ideas

Co-author Network

Publications

TOP 3
C E Schmeink; B I Witte; J Berkhof; C H Lenselink; L F A G Massuger; W J G Melchers; W G V Quint; R L M Bekkers
Prospective follow-up of 2,065 young unscreened women to study human papillomavirus incidence and clearance.
Y P Geels; J M A Pijnenborg; M P M L Snijders; S H M van den Berg-van Erp; Johan Bulten; L F A G Massuger
Absolute depth of myometrial invasion in endometrial cancer is superior to the currently used cut-off value of 50%.
C Lybol; L F A G Massuger; E A Blanken; I A Boere; A K L Reyners; Fred C G J Sweep; C M G Thomas; R Q G C M van Hoesel; R H Verheijen; A M Westermann; PB Ottevanger
Comparing cisplatin-based combination chemotherapy with EMA/CO chemotherapy for the treatment of high risk gestational trophoblastic neoplasia.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of L F A G Massuger (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: C E Schmeink; B I Witte; J Berkhof; C H Lenselink; L F A G Massuger; W J G Melchers; W G V Quint; R L M Bekkers
Prospective follow-up of 2,065 young unscreened women to study human papillomavirus incidence and clearance.
International journal of cancer. Journal international du cancer 2013;133(1):172-81.
2013: Y P Geels; J M A Pijnenborg; M P M L Snijders; S H M van den Berg-van Erp; Johan Bulten; L F A G Massuger
Absolute depth of myometrial invasion in endometrial cancer is superior to the currently used cut-off value of 50%.
Gynecologic oncology 2013;129(2):285-91.
2013: C Lybol; L F A G Massuger; E A Blanken; I A Boere; A K L Reyners; Fred C G J Sweep; C M G Thomas; R Q G C M van Hoesel; R H Verheijen; A M Westermann; PB Ottevanger
Comparing cisplatin-based combination chemotherapy with EMA/CO chemotherapy for the treatment of high risk gestational trophoblastic neoplasia.
European journal of cancer (Oxford, England : 1990) 2013;49(4):860-7.
2012: C Lybol; L F A G Massuger; PB Ottevanger; F C G J Sweep; K Westerdijk; C M G Thomas
Human chorionic gonadotropin (hCG) regression normograms for patients with high-risk gestational trophoblastic neoplasia treated with EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide and vincristine) chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(11):2903-6.
2012: C Lybol; L F A G Massuger; H Mitchell; PB Ottevanger; P M Savage; D Short; Fred C G J Sweep; C M G Thomas; R Harvey; M J Seckl
Relapse rates after two versus three consolidation courses of methotrexate in the treatment of low-risk gestational trophoblastic neoplasia.
Gynecologic oncology 2012;125(3):576-9.
2012: Thijs Roelofsen; Jeroen A W M van der Laak; Maaike A P C van Ham; Léon C L van Kempen; Johan Bulten; L F A G Massuger
Concurrent endometrial intraepithelial carcinoma (EIC) and serous ovarian cancer: can EIC be seen as the precursor lesion?
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2012;22(3):457-64.
2012: L C G van den Einden; Irene A M Van der Avoort; Léon C L van Kempen; J E M Vedder; Johanna M M Grefte; L F A G Massuger; Joanne A de Hullu
Cytology of the vulva: feasibility and preliminary results of a new brush.
British journal of cancer 2012;106(2):269-73.
2012: K A P Meeuwis; P C M van de Kerkhof; J A de Hullu; L F A G Massuger; M M van Rossum
Patients' experience of psoriasis in the genital area.
Dermatology (Basel, Switzerland) 2012;224(3):271-6.
2011: F Hinten; L F A G Massuger; H P van de Nieuwenhof; L C G van den Einden; A G J van der Zee; Johan Bulten; J C M Hendriks; Joanne A de Hullu
Risk factors for short- and long-term complications after groin surgery in vulvar cancer.
British journal of cancer 2011;105(9):1279-87.
2011: Y P Geels; L F A G Massuger; J M A Pijnenborg
Prognostic factors in stage II/III/IV and stages III/IV endometrioid and serous adenocarcinoma of the endometrium. P. Mhawech-Fauceglia, R.F. Herrmann, J. Kesterson, I. Izevbaye, S. Lele, K. Odunsi. Eur J Surg Oncol 2010 Dec;36(12):1195-201.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2011;37(8):734-5; author reply 736.
2011: Roosmarie P de Bie; L F A G Massuger; Judith M J E Bakkers; R L M Bekkers; Wim G V Quint; Channa E Schmeink; Peter J F Snijders; Willem J G Melchers
The indicating FTA elute cartridge a solid sample carrier to detect high-risk HPV and high-grade cervical lesions.
The Journal of molecular diagnostics : JMD 2011;13(4):371-6.
2011: Sandra M E Geurts; Femmie de Vegt; Vivianne C G Tjan-Heijnen; Anne M van Altena; Jos A A M van Dijck; André L M Verbeek; L F A G Massuger
Considering early detection of relapsed ovarian cancer: a review of the literature.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2011;21(5):837-45.
2011: Petronella A J van den Akker; Jos H A Vollebergh; Petra L M Zusterzeel; Anette L Aalders; Kirsten B Kluivers; Rahul A K Samlal; Marc P L M Snijders; L F A G Massuger
Factors influencing the use of frozen section analysis in adnexal masses.
Obstetrics and gynecology 2011;118(1):57-62.
2011: Roosmarie P de Bie; L F A G Massuger; Willem J G Melchers; Maria R J Salet-van der Pol; (Al)bert G Siebers; Judith E M Vedder; Henke C Vergers-Spooren; Johan Bulten; R L M Bekkers
Patients with cervical cancer: why did screening not prevent these cases?
American journal of obstetrics and gynecology 2011;205(1):64.e1-7.
2011: K A P Meeuwis; Joanne A de Hullu; H P van de Nieuwenhof; A W M Evers; L F A G Massuger; P C M van de Kerkhof; Michelle M van Rossum
Quality of life and sexual health in patients with genital psoriasis.
The British journal of dermatology 2011;164(6):1247-55.
2011: Sandra M E Geurts; Anne M van Altena; Femmie de Vegt; Vivianne C G Tjan-Heijnen; L F A G Massuger; Jos A A M van Dijck; André L M Verbeek
No supportive evidence for clinical benefit of routine follow-up in ovarian cancer: a Dutch multicenter study.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2011;21(4):647-53.
2011: Channa E Schmeink; R L M Bekkers; L F A G Massuger; Willem J G Melchers
The potential role of self-sampling for high-risk human papillomavirus detection in cervical cancer screening.
Reviews in medical virology 2011;21(3):139-53.
2011: Hedwig P van de Nieuwenhof; Johan Bulten; Harrie Hollema; Rianne G Dommerholt; L F A G Massuger; Ate G J van der Zee; Joanne A de Hullu; Léon C L van Kempen
Differentiated vulvar intraepithelial neoplasia is often found in lesions, previously diagnosed as lichen sclerosus, which have progressed to vulvar squamous cell carcinoma.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2011;24(2):297-305.
2011: Channa E Schmeink; (Al)bert G Siebers; L F A G Massuger; Willem J G Melchers; Wim G V Quint; R L M Bekkers
Human papillomavirus persistence in young unscreened women, a prospective cohort study.
PloS one 2011;6(11):e27937.
2011: C E Schmeink; K C M Gosens; L F A G Massuger; W J G Melchers; R L M Bekkers
Young adults awareness of HPV and vaccine acceptance after introduction of the HPV vaccine in the Dutch national vaccination program.
European journal of gynaecological oncology 2011;32(5):481-6.
2010: S van der Steen; H P van de Nieuwenhof; L F A G Massuger; Johan Bulten; Joanne A de Hullu
New FIGO staging system of vulvar cancer indeed provides a better reflection of prognosis.
Gynecologic oncology 2010;119(3):520-5.
2010: Anne M van Altena; Eva Kolwijck; Marielle J B Spanjer; Jan C M Hendriks; L F A G Massuger; Joanne A de Hullu
CA125 nadir concentration is an independent predictor of tumor recurrence in patients with ovarian cancer: a population-based study.
Gynecologic oncology 2010;119(2):265-9.
2010: Irene A M Van der Avoort; Hedwig P van de Nieuwenhof; Irene Otte-Höller; Ella Nirmala; Johan Bulten; L F A G Massuger; Jeroen A W M van der Laak; Piet J Slootweg; Joanne A de Hullu; Léon C L van Kempen
High levels of p53 expression correlate with DNA aneuploidy in (pre)malignancies of the vulva.
Human pathology 2010;41(10):1475-85.
2010: Irene A M Van der Avoort; Jeroen A W M van der Laak; Irene Otte-Höller; Hedwig P van de Nieuwenhof; L F A G Massuger; Joanne A de Hullu; Léon C L van Kempen
The prognostic value of blood and lymph vessel parameters in lichen sclerosus for vulvar squamous cell carcinoma development: an immunohistochemical and electron microscopy study.
American journal of obstetrics and gynecology 2010;203(2):167.e1-8.
2010: Eva Kolwijck; Janko Kos; Natasja Obermajer; Paul Span; Chris M G Thomas; L F A G Massuger; Fred C G J Sweep
The balance between extracellular cathepsins and cystatin C is of importance for ovarian cancer.
European journal of clinical investigation 2010;40(7):591-9.
2010: Eva Kolwijck; Charlotte Lybol; Johan Bulten; Jos H A Vollebergh; Ron A Wevers; L F A G Massuger
Prevalence of cysts in epithelial ovarian cancer.
European journal of obstetrics, gynecology, and reproductive biology 2010;151(1):96-100.
2010: Chris M G Thomas; Linda Kerkmeijer; Henk J W Ariaens; Rob C B M van der Steen; L F A G Massuger; Fred C G J Sweep
Pre-evacuation hCG glycoforms in uneventful complete hydatidiform mole and persistent trophoblastic disease.
Gynecologic oncology 2010;117(1):47-52.
2010: Eva Kolwijck; Paul Span; Chris M G Thomas; Johan Bulten; Fred C G J Sweep; L F A G Massuger
Prognostic value of CA 125 in ovarian cyst fluid of patients with epithelial ovarian cancer.
Oncology reports 2010;23(2):579-84.
2010: Eva Kolwijck; Ron A Wevers; Udo F H Engelke; Jannes Woudenberg; Johan Bulten; Henk J Blom; L F A G Massuger
Ovarian cyst fluid of serous ovarian tumors contains large quantities of the brain amino acid N-acetylaspartate.
PloS one 2010;5(4):e10293.
2009: Eva Kolwijck; Udo F H Engelke; Marinette van der Graaf; Arend Heerschap; Henk J Blom; M'hamed Hadfoune; Wim A Buurman; L F A G Massuger; Ron A Wevers
N-acetyl resonances in in vivo and in vitro NMR spectroscopy of cystic ovarian tumors.
NMR in biomedicine 2009;22(10):1093-9.
2009: Eva Kolwijck; Chris M G Thomas; Johan Bulten; L F A G Massuger
Preoperative CA-125 levels in 123 patients with borderline ovarian tumors: a retrospective analysis and review of the literature.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2009;19(8):1335-8.
2009: N Tábora; Judith M J E Bakkers; W G V Quint; L F A G Massuger; J A Matute; Willem J G Melchers; Annabelle Ferrera
Human papillomavirus infection in Honduran women with normal cytology.
Cancer causes & control : CCC 2009;20(9):1663-70.
2009: Eva Kolwijck; Petra L M Zusterzeel; Hennie M J Roelofs; Jan C M Hendriks; Wilbert H M Peters; L F A G Massuger
GSTP1-1 in ovarian cyst fluid and disease outcome of patients with ovarian cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(8):2176-81.
2009: Charlotte H Lenselink; Roosmarie P de Bie; Dennis van Hamont; Judith M J E Bakkers; Wim G V Quint; L F A G Massuger; R L M Bekkers; Willem J G Melchers
Detection and genotyping of human papillomavirus in self-obtained cervicovaginal samples by using the FTA cartridge: new possibilities for cervical cancer screening.
Journal of clinical microbiology 2009;47(8):2564-70.
2009: R P de Bie; H P van de Nieuwenhof; R L M Bekkers; Willem J G Melchers; (Al)bert G Siebers; Johan Bulten; L F A G Massuger; Joanne A de Hullu
Patients with usual vulvar intraepithelial neoplasia-related vulvar cancer have an increased risk of cervical abnormalities.
British journal of cancer 2009;101(1):27-31.
2009: Hedwig P van de Nieuwenhof; Léon C L van Kempen; Joanne A de Hullu; R L M Bekkers; Johan Bulten; Willem J G Melchers; L F A G Massuger
The etiologic role of HPV in vulvar squamous cell carcinoma fine tuned.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(7):2061-7.
2009: Gerdy B ten Dam; Shuhei Yamada; Fumi Kobayashi; Anurag Purushothaman; Els M A van de Westerlo; Johan Bulten; Anders Malmström; Kazuyuki Sugahara; L F A G Massuger; Toin H van Kuppevelt
Dermatan sulfate domains defined by the novel antibody GD3A12, in normal tissues and ovarian adenocarcinomas.
Histochemistry and cell biology 2009;132(1):117-27.
2009: Linda Kerkmeijer; Chris M G Thomas; R Harvey; Fred C G J Sweep; H Mitchell; L F A G Massuger; M J Seckl
External validation of serum hCG cutoff levels for prediction of resistance to single-agent chemotherapy in patients with persistent trophoblastic disease.
British journal of cancer 2009;100(6):979-84.
2009: Hedwig P van de Nieuwenhof; L F A G Massuger; Irene A M Van der Avoort; R L M Bekkers; Mariel Casparie; Wim Abma; Léon C L van Kempen; Joanne A de Hullu
Vulvar squamous cell carcinoma development after diagnosis of VIN increases with age.
European journal of cancer (Oxford, England : 1990) 2009;45(5):851-6.
2009: Linda G W Kerkmeijer; L F A G Massuger; Marianne J Ten Kate-Booij; Fred C G J Sweep; Chris M G Thomas
Earlier diagnosis and serum human chorionic gonadotropin regression in complete hydatidiform moles.
Obstetrics and gynecology 2009;113(2 Pt 1):326-31.
2008: (Al)bert G Siebers; Paul J J M Klinkhamer; Marc Arbyn; Amidu O Raifu; L F A G Massuger; Johan Bulten
Cytologic detection of cervical abnormalities using liquid-based compared with conventional cytology: a randomized controlled trial.
Obstetrics and gynecology 2008;112(6):1327-34.
2008: C H Lenselink; C E Schmeink; Willem J G Melchers; L F A G Massuger; J C M Hendriks; Dennis van Hamont; R L M Bekkers
Young adults and acceptance of the human papillomavirus vaccine.
Public health 2008;122(12):1295-301.
2008: H P van de Nieuwenhof; Maaike A P C van Ham; F K Lotgering; L F A G Massuger
First case of vaginal radical trachelectomy in a pregnant patient.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2008;18(6):1381-5.
2008: A L M Oei; María Moreno; René H M Verheijen; Fred C G J Sweep; Chris M G Thomas; L F A G Massuger; Silvia von Mensdorff-Pouilly
Induction of IgG antibodies to MUC1 and survival in patients with epithelial ovarian cancer.
International journal of cancer. Journal international du cancer 2008;123(8):1848-53.
2008: M J ten Kate-Booij; C A R Lok; R H M Verheijen; L F A G Massuger; N E van Trommel
[Trophoblastic diseases].
Nederlands tijdschrift voor geneeskunde 2008;152(41):2219-24.
2008: A L M Oei; Fred C G J Sweep; Anneke Geurts-Moespot; Doorléne T H van Tienoven; Silvia von Mensdorff-Pouilly; Chris M G Thomas; L F A G Massuger
Human anti-mouse IgM and IgG responses in ovarian cancer patients after radioimmunotherapy with 90Y-muHMFG1.
Anticancer research 2008;28(5A):2721-5.
2008: A L M Oei; Fred C G J Sweep; Chris M G Thomas; Otto Boerman; L F A G Massuger
The use of monoclonal antibodies for the treatment of epithelial ovarian cancer (review).
International journal of oncology 2008;32(6):1145-57.
2008: H P van de Nieuwenhof; I A M van der Avoort; L F A G Massuger; Joanne A de Hullu
Letter to the Editor concerning "Topical imiquimod can reverse vulvar intraepithelial neoplasia: a randomized, double blinded study." Gynecologic Oncology 107 (2007) 219-222.
Gynecologic oncology 2008;109(3):430-1; author reply 431.
2008: Nelba Tábora; Annabelle Ferrera; Judith M J E Bakkers; L F A G Massuger; Willem J G Melchers
High HPV 16 viral load is associated with increased cervical dysplasia in Honduran women.
The American journal of tropical medicine and hygiene 2008;78(5):843-6.
2008: A L M Oei; Fred C G J Sweep; L F A G Massuger; André J Olthaar; Chris M G Thomas
Transient human anti-mouse antibodies (HAMA) interference in CA 125 measurements during monitoring of ovarian cancer patients treated with murine monoclonal antibody.
Gynecologic oncology 2008;109(2):199-202.
2008: Dennis van Hamont; J Bulten; H Shirango; Willem J G Melchers; L F A G Massuger; P C M de Wilde
Biological behavior of CIN lesions is predictable by multiple parameter logistic regression models.
Carcinogenesis 2008;29(4):840-5.
2008: Dennis van Hamont; R L M Bekkers; L F A G Massuger; Willem J G Melchers
Detection, management, and follow-up of pre-malignant cervical lesions and the role for human papillomavirus.
Reviews in medical virology 2008;18(2):117-32.
2008: Nienke E van Trommel; H Ngo Duc; L F A G Massuger; C P T Schijf; C G J Sweep; C M G Thomas
Early identification of persistent trophoblastic disease with serum hCG concentration ratios.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2008;18(2):318-23.
2008: Charlotte H Lenselink; Marloes M J G Gerrits; Willem J G Melchers; L F A G Massuger; Dennis van Hamont; R L M Bekkers
Parental acceptance of Human Papillomavirus vaccines.
European journal of obstetrics, gynecology, and reproductive biology 2008;137(1):103-7.
2008: Anne M van Altena; Geertruida J Wijnberg; Eva Kolwijck; Joanne A de Hullu; L F A G Massuger
A patient with bilateral immature ovarian teratoma presenting with paraneoplastic encephalitis.
Gynecologic oncology 2008;108(2):445-8.
2008: H P van de Nieuwenhof; L F A G Massuger; Joanne A de Hullu; Maaike A P C van Ham; J A A M van Dijck; (Al)bert G Siebers; R L M Bekkers
Significant decrease of adenocarcinoma in situ not reflected in cervical adenocarcinoma incidence in the Netherlands 1989-2003.
British journal of cancer 2008;98(1):165-7.
2008: C M G Thomas; Erik A Boss; Henk Boonstra; Doorléne T H van Tienoven; C G J Sweep; L F A G Massuger
Gonadotropins and female sex steroid hormones in cyst fluid and serum from patients with ovarian tumors.
European journal of gynaecological oncology 2008;29(5):468-72.
2007: Eva Kolwijck; Erik A Boss; Anne M van Altena; Louk V Beex; L F A G Massuger
Stage IV epithelial ovarian carcinoma in an 18 year old patient presenting with a Sister Mary Joseph's nodule and metastasis in both breasts: a case report and review of the literature.
Gynecologic oncology 2007;107(3):583-5.
2007: Anne M van Altena; Joanne A de Hullu; L F A G Massuger
Letter commenting on the article "CA 125 expression pattern, prognosis and correlation with serum CA 125 in ovarian tumor patients" (104:508-515) by Hogdall, et al and on the Editorial "CA 125: megadaltons of novel opportunities" (104:505-507).
Gynecologic oncology 2007;107(2):355-6.
2007: Nienke E van Trommel; L F A G Massuger; Paul Span; Fred C G J Sweep; Chris M G Thomas
Early identification of treatment resistance in GTN.
The lancet oncology 2007;8(10):866-7.
2007: Gerdy B ten Dam; Els M A van de Westerlo; Anurag Purushothaman; Radu V Stan; Johan Bulten; Fred C G J Sweep; L F A G Massuger; Kazuyuki Sugahara; Toin H van Kuppevelt
Antibody GD3G7 selected against embryonic glycosaminoglycans defines chondroitin sulfate-E domains highly up-regulated in ovarian cancer and involved in vascular endothelial growth factor binding.
The American journal of pathology 2007;171(4):1324-33.
2007: A L M Oei; L F A G Massuger; Wim J G Oyen
Extraperitoneal leakage as a possible explanation for failure of one-time intraperitoneal treatment in ovarian cancer.
Cancer biotherapy & radiopharmaceuticals 2007;22(4):508-14.
2007: A L M Oei; Otto Boerman; Anneke Geurts-Moespot; Julliëtte E M van Eerd; Doorléne T H van Tienoven; N Courtenay-Luck; Chris M G Thomas; L F A G Massuger; Fred C G J Sweep
Development of ELISAs for quantification of HMFG1-specific human anti-mouse IgG and IgM antibodies.
The International journal of biological markers 2007;22(3):167-71.
2007: Irene A M Van der Avoort; Jeroen A W M van der Laak; Ard Paffen; Johanna M M Grefte; L F A G Massuger; Peter C M de Wilde; Joanne A de Hullu; Johan Bulten
MIB1 expression in basal cell layer: a diagnostic tool to identify premalignancies of the vulva.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2007;20(7):770-8.
2007: Linda Kerkmeijer; Sabien Wielsma; L F A G Massuger; Fred C G J Sweep; Chris M G Thomas
Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
Gynecologic oncology 2007;106(1):142-6.
2007: A L M Oei; René H M Verheijen; Michael Seiden; Benedict B Benigno; Alberto Lopes; John Soper; Agamemnon A Epenetos; L F A G Massuger
Decreased intraperitoneal disease recurrence in epithelial ovarian cancer patients receiving intraperitoneal consolidation treatment with yttrium-90-labeled murine HMFG1 without improvement in overall survival.
International journal of cancer. Journal international du cancer 2007;120(12):2710-4.
2007: Brenda B J Hermsen; Roelien I Olivier; René H M Verheijen; Marc van Beurden; Joanne A de Hullu; L F A G Massuger; Curt W Burger; Cecile T M Brekelmans; Marian J E Mourits; Geertruida H de Bock; Katja N Gaarenstroom; Hester Van Boven; T M Mooij; Matti A Rookus
No efficacy of annual gynaecological screening in BRCA1/2 mutation carriers; an observational follow-up study.
British journal of cancer 2007;96(9):1335-42.
2007: (Al)bert G Siebers; L F A G Massuger; Johan Bulten
Referral compliance, outcome and predictors of CIN after repeated borderline cervical smears in the Netherlands.
Cytopathology : official journal of the British Society for Clinical Cytology 2007;18(2):96-104.
2007: Maaike A P C van Ham; Dennis van Hamont; R L M Bekkers; Johan Bulten; Willem J G Melchers; L F A G Massuger
High-risk HPV presence in cervical specimens after a large loop excision of the cervical transformation zone: significance of newly detected hr-HPV genotypes.
Journal of medical virology 2007;79(3):314-9.
2007: Joanna B Madalinska; Marc van Beurden; Eveline M A Bleiker; Heiddis B Valdimarsdottir; Lottie Lubsen-Brandsma; L F A G Massuger; Marian J E Mourits; Katja N Gaarenstroom; Eleonora B L van Dorst; Hans van der Putten; Henk Boonstra; Neil K Aaronson
Predictors of prophylactic bilateral salpingo-oophorectomy compared with gynecologic screening use in BRCA1/2 mutation carriers.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(3):301-7.
2006: Nienke E van Trommel; Fred C G J Sweep; H Alec Ross; L F A G Massuger; Chris M G Thomas
Comparison of human chorionic gonadotropin +beta and invasive trophoblast antigen disappearance rates in serum after evacuation of molar pregnancy.
International journal of molecular medicine 2006;18(4):705-11.
2006: Jurgen M J Piek; Josephine C Dorsman; L F A G Massuger; Anca C Ansink; Jitske Weegenaar; Avi Shvarts; Peter Kenemans; René H M Verheijen
BRCA1 and p53 protein expression in cultured ovarian surface epithelial cells derived from women with and without a BRCA1 germline mutation.
Archives of gynecology and obstetrics 2006;274(6):327-31.
2006: RT Netea-Maier; Willy-Anne Nieuwlaat; C G J Sweep; P Wesseling; L F A G Massuger; Ad R M M Hermus
Virilization due to ovarian androgen hypersecretion in a patient with ectopic adrenocorticotrophic hormone secretion caused by a carcinoid tumour: case report.
Human reproduction (Oxford, England) 2006;21(10):2601-5.
2006: L H M Gerritzen; Johanna M M Grefte; Nicoline Hoogerbrugge; Johan Bulten; L F A G Massuger; Joanne A de Hullu
A substantial part of the fallopian tube is left after standard prophylactic bilateral salpingo-oophorectomy.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2006;16(5):1940-4.
2006: Dennis van Hamont; Maaike A P C van Ham; Judith M J E Bakkers; L F A G Massuger; Willem J G Melchers
Evaluation of the SPF10-INNO LiPA human papillomavirus (HPV) genotyping test and the roche linear array HPV genotyping test.
Journal of clinical microbiology 2006;44(9):3122-9.
2006: Dennis van Hamont; L H C Nissen; (Al)bert G Siebers; Jan C M Hendriks; Willem J G Melchers; Jan A M Kremer; L F A G Massuger
Abnormal cervical cytology in women eligible for IVF.
Human reproduction (Oxford, England) 2006;21(9):2359-63.
2006: Joanna B Madalinska; Marc van Beurden; Eveline M A Bleiker; Heiddis B Valdimarsdottir; Judith Hollenstein; L F A G Massuger; Katja N Gaarenstroom; Marian J E Mourits; René H M Verheijen; Eleonora B L van Dorst; Hans van der Putten; Ko van der Velden; Henk Boonstra; Neil K Aaronson
The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(22):3576-82.
2006: Johan Bulten; Irene A M Van der Avoort; Willem J G Melchers; L F A G Massuger; Johanna M M Grefte; A G J M Hanselaar; Peter C M de Wilde
p14ARF and p16INK4A, two products of the same gene, are differently expressed in cervical intraepithelial neoplasia.
Gynecologic oncology 2006;101(3):487-94.
2006: (Al)bert G Siebers; André L M Verbeek; L F A G Massuger; Johanna M M Grefte; Johan Bulten
Normal appearing endometrial cells in cervical smears of asymptomatic postmenopausal women have predictive value for significant endometrial pathology.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2006;16(3):1069-74.
2006: Jozien Helleman; maurice jansen; Paul Span; Iris L van Staveren; L F A G Massuger; Marion E Meijer-Van Gelder; Fred C G J Sweep; Patricia C Ewing; M E L van der Burg; Gerrit Stoter; Kees Nooter; Petronella Berns
Molecular profiling of platinum resistant ovarian cancer.
International journal of cancer. Journal international du cancer 2006;118(8):1963-71.
2006: A L M Oei; L F A G Massuger; Johan Bulten; M J L Ligtenberg; Nicoline Hoogerbrugge; Joanne A de Hullu
Surveillance of women at high risk for hereditary ovarian cancer is inefficient.
British journal of cancer 2006;94(6):814-9.
2006: Dennis van Hamont; Maaike A P C van Ham; P H T H Struik-van der Zanden; K G G Keijser; Johan Bulten; Willem J G Melchers; L F A G Massuger
Long-term follow-up after large-loop excision of the transformation zone: evaluation of 22 years treatment of high-grade cervical intraepithelial neoplasia.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2006;16(2):615-9.
2006: R L M Bekkers; C J L M Meijer; L F A G Massuger; Peter J F Snijders; Willem J G Melchers
Effects of HPV detection in population-based screening programmes for cervical cancer; a Dutch moment.
Gynecologic oncology 2006;100(3):451-4.
2006: René H M Verheijen; L F A G Massuger; Benedict B Benigno; Agamemnon A Epenetos; Alberto Lopes; John Soper; Janica Markowska; Rostislav Vyzula; Tom Jobling; Gordon Stamp; Gregory Spiegel; Dennis Thurston; Theo Falke; Joanna Lambert; Michael Seiden
Phase III trial of intraperitoneal therapy with yttrium-90-labeled HMFG1 murine monoclonal antibody in patients with epithelial ovarian cancer after a surgically defined complete remission.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(4):571-8.
2006: H Ngo Duc; Nienke E van Trommel; Fred C G J Sweep; L F A G Massuger; Chris M G Thomas
Clinical utility of hyperglycosylated hCG in serum taken before hydatidiform mole evacuation to predict persistent trophoblastic disease.
The International journal of biological markers 2006;21(1):45-9.
2006: Nienke E van Trommel; L F A G Massuger; C P T Schijf; Marianne J Ten Kate-Booij; Fred C G J Sweep; Chris M G Thomas
Early identification of resistance to first-line single-agent methotrexate in patients with persistent trophoblastic disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(1):52-8.
2006: Irene A M Van der Avoort; H Shirango; B M Hoevenaars; Johanna M M Grefte; Joanne A de Hullu; Peter C M de Wilde; Johan Bulten; Willem J G Melchers; L F A G Massuger
Vulvar squamous cell carcinoma is a multifactorial disease following two separate and independent pathways.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2006;25(1):22-9.
2005: Erik A Boss; Ron J T Van Golde; C C M Beerendonk; L F A G Massuger
Pregnancy after radical trachelectomy: a real option?
Gynecologic oncology 2005;99(3 Suppl 1):S152-6.
2005: Nienke E van Trommel; Chris M G Thomas; L F A G Massuger; Fred C G J Sweep
Second curettage in persistent trophoblastic disease (PTD): the need for univocal definition of PTD.
Gynecologic oncology 2005;99(1):250-1; author reply 251.
2005: Nienke E van Trommel; Fred C G J Sweep; C P T Schijf; L F A G Massuger; Chris M G Thomas
Diagnosis of hydatidiform mole and persistent trophoblastic disease: diagnostic accuracy of total human chorionic gonadotropin (hCG), free hCG {alpha}- and {beta}-subunits, and their ratios.
European journal of endocrinology / European Federation of Endocrine Societies 2005;153(4):565-75.
2005: Joanna B Madalinska; Judith Hollenstein; Eveline M A Bleiker; Marc van Beurden; Heiddis B Valdimarsdottir; L F A G Massuger; Katja N Gaarenstroom; Marian J E Mourits; René H M Verheijen; Eleonora B L van Dorst; Hans van der Putten; Ko van der Velden; Henk Boonstra; Neil K Aaronson
Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(28):6890-8.
2005: Nienke E van Trommel; L F A G Massuger; René H M Verheijen; Fred C G J Sweep; Chris M G Thomas
The curative effect of a second curettage in persistent trophoblastic disease: a retrospective cohort survey.
Gynecologic oncology 2005;99(1):6-13.
2005: Maaike A P C van Ham; Judith M J E Bakkers; Gonneke K Harbers; Wim Quint; L F A G Massuger; Willem J G Melchers
comparison of two commercial assays for detection of human papillomavirus (HPV) in cervical scrape specimens: validation of the Roche AMPLICOR HPV test as a means to screen for HPV genotypes associated with a higher risk of cervical disorders.
Journal of clinical microbiology 2005;43(6):2662-7.
2005: R L M Bekkers; Irene A M Van der Avoort; Willem J G Melchers; Johan Bulten; Peter C M de Wilde; L F A G Massuger
Down regulation of estrogen receptor expression is an early event in human papillomavirus infected cervical dysplasia.
European journal of gynaecological oncology 2005;26(4):376-82.
2004: Frederic Amant; Edwin Steenkiste; K Schurmans; Lieve Verbist; Vera M Abeler; G Tulunay; Eric De Jonge; L F A G Massuger; Philippe Moerman; Ignace Vergote
Immunohistochemical expression of CD10 antigen in uterine adenosarcoma.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2004;14(6):1118-21.
2004: Carolien M Kets; Martinus F Niermeijer; L F A G Massuger; Nicoline Hoogerbrugge
[In cases of familial ovarian cancer, always consider the risk of breast cancer].
Nederlands tijdschrift voor geneeskunde 2004;148(35):1709-11.
2004: Marcel Janssen; Cathelijne Frielink; Ingrid Dijkgraaf; Wim J G Oyen; D Scott Edwards; Shuang Liu; Milind Rajopadhye; L F A G Massuger; Frans H M Corstens; Otto Boerman
Improved tumor targeting of radiolabeled RGD peptides using rapid dose fractionation.
Cancer biotherapy & radiopharmaceuticals 2004;19(4):399-404.
2004: Frederic Amant; Katrien Schurmans; Edwin Steenkiste; Lieve Verbist; Vera M Abeler; Gökhan Tulunay; Eric De Jonge; L F A G Massuger; Philippe Moerman; Ignace Vergote
Immunohistochemical determination of estrogen and progesterone receptor positivity in uterine adenosarcoma.
Gynecologic oncology 2004;93(3):680-5.
2004: R L M Bekkers; L F A G Massuger; Johan Bulten; Willem J G Melchers
Epidemiological and clinical aspects of human papillomavirus detection in the prevention of cervical cancer.
Reviews in medical virology 2004;14(2):95-105.
2004: Jurgen M J Piek; Josephine C Dorsman; Avi Shvarts; Anca C Ansink; L F A G Massuger; Piet Scholten; Paulus van Diest; Jan C Dijkstra; Jitske Weegenaar; Peter Kenemans; René H M Verheijen
Cultures of ovarian surface epithelium from women with and without a hereditary predisposition to develop female adnexal carcinoma.
Gynecologic oncology 2004;92(3):819-26.
2004: R L M Bekkers; A G J M Hanselaar; Willem J G Melchers; J H M van Schaik; Henk Boonstra; L F A G Massuger
Management of patients with two consecutive ASC-US smears.
European journal of gynaecological oncology 2004;25(6):677-81.
2004: PJ van Kesteren; Johan Bulten; C P T Schijf; Henk Boonstra; L F A G Massuger
Malignant peritoneal mesothelioma in a 76-year-old woman with a history of asbestos fiber ingestion.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2004;14(1):162-5.
2003: M L Janssen; W Pels; L F A G Massuger; Wim J G Oyen; Henk Boonstra; Frans H M Corstens; Otto Boerman
Intraperitoneal radioimmunotherapy in an ovarian carcinoma mouse model: Effect of the radionuclide.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2003;13(5):607-13.
2003: R L M Bekkers; Johan Bulten; A Wiersma-van Tilburg; M Mravunac; C P T Schijf; L F A G Massuger; Wim Quint; Willem J G Melchers
Coexisting high-grade glandular and squamous cervical lesions and human papillomavirus infections.
British journal of cancer 2003;89(5):886-90.
2003: Jurgen M J Piek; René H M Verheijen; Peter Kenemans; L F A G Massuger; Hans Bulten; Paulus van Diest
BRCA1/2-related ovarian cancers are of tubal origin: a hypothesis.
Gynecologic oncology 2003;90(2):491.
2003: R L M Bekkers; A G J M Hanselaar; Willem J G Melchers; J H M van Schaik; Henk Boonstra; L F A G Massuger
[Wait-and-see policy versus loop excision after two consecutive Pap-2 cervical smears: over time less surgery and an equivalent outcome; no substantial contribution to be expected from the detection of high risk human papillomavirus].
Nederlands tijdschrift voor geneeskunde 2003;147(7):302-6.
2003: Nicoline Hoogerbrugge; Peter Bult; L M de Widt-Levert; Louk V A M Beex; Lambertus A L M Kiemeney; M J L Ligtenberg; L F A G Massuger; Carla Boetes; Peggy Manders; Han G Brunner
High prevalence of premalignant lesions in prophylactically removed breasts from women at hereditary risk for breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(1):41-5.
2002: Marcel Janssen; Wim J G Oyen; L F A G Massuger; Cathelijne Frielink; Ingrid Dijkgraaf; D Scott Edwards; Milind Radjopadhye; Frans H M Corstens; Otto Boerman
Comparison of a monomeric and dimeric radiolabeled RGD-peptide for tumor targeting.
Cancer biotherapy & radiopharmaceuticals 2002;17(6):641-6.
2002: R L M Bekkers; M van der Donck; F M Klaver; Agnes van Minnen; L F A G Massuger
Variables influencing anxiety of patients with abnormal cervical smears referred for colposcopy.
Journal of psychosomatic obstetrics and gynaecology 2002;23(4):257-61.
2002: R L M Bekkers; Willem J G Melchers; Judith M J E Bakkers; A G J M Hanselaar; Wim Quint; Henk Boonstra; L F A G Massuger
The role of genotype-specific human papillomavirus detection in diagnosing residual cervical intraepithelial neoplasia.
International journal of cancer. Journal international du cancer 2002;102(2):148-51.
2002: Marcel L Janssen; Wim J G Oyen; Ingrid Dijkgraaf; L F A G Massuger; Cathelijne Frielink; D Scott Edwards; Milind Rajopadhye; Henk Boonstra; Frans H M Corstens; Otto Boerman
Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model.
Cancer research 2002;62(21):6146-51.
2002: Johan Bulten; Willem J G Melchers; Maria M Kooy-Smits; Peter C M de Wilde; Pino J Poddighe; Johanna C M Robben; Merryn V E Macville; L F A G Massuger; Judith M J E Bakkers; A G J M Hanselaar
Numerical aberrations of chromosome 1 in cervical intraepithelial neoplasia are strongly associated with infection with high-risk human papillomavirus types.
The Journal of pathology 2002;198(3):300-9.
2002: R L M Bekkers; K G G Keyser; Johan Bulten; A G J M Hanselaar; C P T Schijf; Henk Boonstra; L F A G Massuger
The value of loop electrosurgical conization in the treatment of stage IA1 microinvasive carcinoma of the uterine cervix.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2002;12(5):485-9.
2002: Maaike A P C van Ham; Willem J G Melchers; A G J M Hanselaar; R L M Bekkers; Henk Boonstra; L F A G Massuger
Fluctuations in prevalence of cervical human papillomavirus in women frequently sampled during a single menstrual cycle.
British journal of cancer 2002;87(4):373-6.
2002: R L M Bekkers; Willem J G Melchers; Johan Bulten; Henk Boonstra; Wim Quint; A G J M Hanselaar; L F A G Massuger
Localized distribution of human papillomavirus genotypes in the uterine cervix.
European journal of gynaecological oncology 2002;23(3):203-6.
2002: Erik A Boss; L F A G Massuger; Chris M G Thomas; Anneke Geurts-Moespot; J H M van Schaik; Henk Boonstra; C G J Sweep
Clinical value of components of the plasminogen activation system in ovarian cyst fluid.
Anticancer research 2002;22(1A):275-82.
2001: Mark J Stoutjesdijk; Carla Boetes; Gerrit J Jager; Louk V A M Beex; Peter Bult; J H C L Hendriks; R J Laheij; L F A G Massuger; Lya E van Die; Theo Wobbes; Jelle O Barentsz
Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer.
Journal of the National Cancer Institute 2001;93(14):1095-102.
2001: Erik A Boss; L F A G Massuger; Lucas A M Pop; Lia C G Verhoef; Henkjan J Huisman; Henk Boonstra; Jelle O Barentsz
Post-radiotherapy contrast enhancement changes in fast dynamic MRI of cervical carcinoma.
Journal of magnetic resonance imaging : JMRI 2001;13(4):600-6.
2001: Erik A Boss; L F A G Massuger; Chris M G Thomas; Anneke Geurts-Moespot; Henk Boonstra; C G J Sweep
Vascular endothelial growth factor in ovarian cyst fluid.
Cancer 2001;91(2):371-7.
2001: Erik A Boss; Wilbert H M Peters; Hennie M J Roelofs; Henk Boonstra; Eric A P Steegers; L F A G Massuger
Glutathione S-transferases P1-1 and A1-1 in ovarian cyst fluids.
European journal of gynaecological oncology 2001;22(6):427-32.
2000: Erik A Boss; Sytske H Moolenaar; L F A G Massuger; Henk Boonstra; Udo F H Engelke; Jan G N de Jong; Ron A Wevers
High-resolution proton nuclear magnetic resonance spectroscopy of ovarian cyst fluid.
NMR in biomedicine 2000;13(5):297-305.
2000: Erik A Boss; Jelle O Barentsz; L F A G Massuger; Henk Boonstra
The role of MR imaging in invasive cervical carcinoma.
European radiology 2000;10(2):256-70.
1999: A G J M Hanselaar; Erik A Boss; L F A G Massuger; J L Bernheim
Cytologic examination to detect clear cell adenocarcinoma of the vagina or cervix.
Gynecologic oncology 1999;75(3):338-44.
1999: NP Koper; L F A G Massuger; Chris M G Thomas; C Beyer; M J Crooy
An illustration of the clinical relevance of detecting human antimouse antibody interference by affinity chromatography.
European journal of obstetrics, gynecology, and reproductive biology 1999;86(2):203-5.
1999: R L M Bekkers; Wim Willemsen; C P T Schijf; L F A G Massuger; Johan Bulten; J M Merkus
Leiomyomatosis peritonealis disseminata: does malignant transformation occur? A literature review.
Gynecologic oncology 1999;75(1):158-63.
1999: R L M Bekkers; L F A G Massuger; P P Berg; U G Haelst; Johan Bulten
Uterine malignant leiomyoblastoma (epithelioid leiomyosarcoma) during pregnancy.
Gynecologic oncology 1999;72(3):433-6.
1998: NP Koper; L F A G Massuger; Chris M G Thomas; Lambertus A L M Kiemeney; André L M Verbeek
Serum CA 125 measurements to identify patients with endometrial cancer who require lymphadenectomy.
Anticancer research 1998;18(3B):1897-902.
1998: L F A G Massuger; PB Van Vierzen; Udo F H Engelke; Arend Heerschap; Ron A Wevers
1H-magnetic resonance spectroscopy: a new technique to discriminate benign from malignant ovarian tumors.
Cancer 1998;82(9):1726-30.
1998: C C M Beerendonk; L F A G Massuger; A M Lucassen; J G Lerou; P P van den Berg
[Circulatory arrest following sulprostone administration in postpartum hemorrhage].
Nederlands tijdschrift voor geneeskunde 1998;142(4):195-7.
1998: NP Koper; Chris M G Thomas; L F A G Massuger; M F Segers; André J Olthaar; André L M Verbeek
Quantitation of IgG and IgM human anti-mouse antibodies (HAMA) interference in CA 125 measurements using affinity chromatography.
Clinical chemistry and laboratory medicine : CCLM / FESCC 1998;36(1):23-8.
1997: NP Koper; Chris M G Thomas; L F A G Massuger; M F Segers; Lambertus A L M Kiemeney; André L M Verbeek
Comparison of four 'second generation' immunoassay systems to determine CA 125 in serum by using a graphical approach to method comparison analysis.
European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies 1997;35(8):617-23.
1997: L F A G Massuger; NP Koper; Chris M G Thomas; K E Dom; C P T Schijf
Improvement of clinical staging in cervical cancer with serum squamous cell carcinoma antigen and CA 125 determinations.
Gynecologic oncology 1997;64(3):473-6.
1996: NP Koper; Lambertus A L M Kiemeney; L F A G Massuger; Chris M G Thomas; C P T Schijf; André L M Verbeek
Ovarian cancer incidence (1989-1991) and mortality (1954-1993) in The Netherlands.
Obstetrics and gynecology 1996;88(3):387-93.
1996: J G Tibben; Otto Boerman; L F A G Massuger; C P T Schijf; RA Claessens; Frans H M Corstens
Pharmacokinetics, biodistribution and biological effects of intravenously administered bispecific monoclonal antibody OC/TR F(ab')2 in ovarian carcinoma patients.
International journal of cancer. Journal international du cancer 1996;66(4):477-83.
1995: J G Tibben; Chris M G Thomas; L F A G Massuger; M F Segers; C P T Schijf; Frans H M Corstens; Otto Boerman
Humoral anti-OV-TL 3 response after the intravenous administration of radiolabelled Fab' or F(ab')2 fragments in ovarian cancer patients.
Nuclear medicine communications 1995;16(10):853-9.
1995: Otto Boerman; J G Tibben; L F A G Massuger; RA Claessens; Frans H M Corstens
Tumour targeting of the anti-ovarian carcinoma x anti-CD3/TCR bispesific monoclonal antibody OC/TR and its parental MOv18 antibody in experimental ovarian cancer.
Anticancer research 1995;15(5B):2169-74.
1995: Chris M G Thomas; L F A G Massuger; M F Segers; C P T Schijf; W H Doesburg; T Wobbes
Analytical and clinical performance of improved Abbott IMx CA 125 assay: comparison with Abbott CA 125 RIA.
Clinical chemistry 1995;41(2):211-6.
1994: J G Tibben; L F A G Massuger; Otto Boerman; G F Borm; RA Claessens; Frans H M Corstens
Effect of the route of administration on the biodistribution of radioiodinated OV-TL 3 F(ab')2 in experimental ovarian cancer.
European journal of nuclear medicine 1994;21(11):1183-90.
1994: J G Tibben; L F A G Massuger; Otto Boerman; RA Claessens; G F Borm; Koon Pak; EB Koenders; Frans H M Corstens
Decreased kidney uptake of technetium-99m-labelled Fab' fragments in ovarian carcinoma bearing nude mice using a cleavable chelator.
Nuclear medicine and biology 1994;21(1):17-24.
1993: J G Tibben; Otto Boerman; RA Claessens; Frans H M Corstens; M van Deuren; P H de Mulder; J W van der Meer; K G Keijser; L F A G Massuger
Cytokine release in an ovarian carcinoma patient following intravenous administration of bispecific antibody OC/TR F(ab')2.
Journal of the National Cancer Institute 1993;85(12):1003-4.
1993: C A Yedema; Peter Kenemans; Chris M G Thomas; L F A G Massuger; T Wobbes; Rob A Verstraeten; Gerard J van Kamp; JH Hilgers
CA 125 serum levels in the early post-operative period do not reflect tumour reduction obtained by cytoreductive surgery.
European journal of cancer (Oxford, England : 1990) 1993;29A(7):966-71.
1992: J G Tibben; L F A G Massuger; RA Claessens; C P T Schijf; Koon Pak; S P Strijk; Peter Kenemans; Frans H M Corstens
Tumour detection and localization using 99Tcm-labelled OV-TL 3 Fab' in patients suspected of ovarian cancer.
Nuclear medicine communications 1992;13(12):885-93.
1992: L F A G Massuger; Chris M G Thomas; M F Segers; Frans H M Corstens; René H M Verheijen; Peter Kenemans; Lambert G Poels
Specific and nonspecific immunoassays to detect HAMA after administration of indium-111-labeled OV-TL 3 F(ab')2 monoclonal antibody to patients with ovarian cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1992;33(11):1958-63.
1992: Wilhelmina C A M Buijs; L F A G Massuger; RA Claessens; Peter Kenemans; Frans H M Corstens
Dosimetric evaluation of immunoscintigraphy using indium-111-labeled monoclonal antibody fragments in patients with ovarian cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1992;33(6):1113-20.
1991: L F A G Massuger; Otto Boerman; Frans H M Corstens; René H M Verheijen; RA Claessens; Lambert G Poels; W J van den Broek; Peter Kenemans
Biodistribution of iodine-125 and indium-111 labeled OV-TL 3 intact antibodies and F(ab')2 fragments in tumor-bearing athymic mice.
Anticancer research 1991;11(6):2051-7.
1991: L F A G Massuger; Peter Kenemans; RA Claessens; René H M Verheijen; Frans H M Corstens
Detection and localization of ovarian cancer with radiolabeled monoclonal antibodies.
European journal of obstetrics, gynecology, and reproductive biology 1991;41(1):47-63.
1991: L F A G Massuger; RA Claessens; Peter Kenemans; René H M Verheijen; Otto Boerman; A P Meeuwis; C P T Schijf; Wilhelmina C A M Buijs; T G Hanselaar; Frans H M Corstens
Kinetics and biodistribution in relation to tumour detection with 111In-labelled OV-TL 3 F(ab')2 in patients with ovarian cancer.
Nuclear medicine communications 1991;12(7):593-609.
1991: K A Yedema; Peter Kenemans; T Wobbes; Gerard J van Kamp; H W de Bruijn; Chris M G Thomas; L F A G Massuger; C P T Schijf; GG Bon; Jan B Vermorken
Carcinoma-associated mucin serum markers CA M26 and CA M29: efficacy in detecting and monitoring patients with cancer of the breast, colon, ovary, endometrium and cervix.
International journal of cancer. Journal international du cancer 1991;47(2):170-9.
1991: L F A G Massuger; RA Claessens; Koon Pak; Otto Boerman; P E Daddona; EB Koenders; Peter Kenemans; Frans H M Corstens
Tissue distribution of 99mTc, 111In and 123I-OV-TL 3 Fab' in ovarian carcinoma bearing nude mice.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1991;18(1):77-83.
1990: L F A G Massuger; Peter Kenemans; RA Claessens; René H M Verheijen; C P T Schijf; S P Strijk; Lambert G Poels; R G van Hoesel; Frans H M Corstens
Immunoscintigraphy of ovarian cancer with indium-111-labeled OV-TL 3 F(ab')2 monoclonal antibody.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1990;31(11):1802-10.
1990: Otto Boerman; L F A G Massuger; K Makkink; C Thomas; Peter Kenemans; Lambert G Poels
Comparative in vitro binding characteristics and biodistribution in tumor-bearing athymic mice of anti-ovarian carcinoma monoclonal antibodies.
Anticancer research 1990;10(5A):1289-95.
1990: L F A G Massuger; R Claessens; Peter Kenemans; T Hanselaar; Frans H M Corstens
Nonantigen-specific tissue localization of monoclonal antibodies.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1990;31(8):1438.
1989: Otto Boerman; K Makkink; L F A G Massuger; C Thomas; Peter Kenemans; T Hanselaar; Lambert G Poels
Monoclonal antibodies against ovarian carcinoma-associated antigens, raised by immunization with cyst fluids.
Anticancer research 1989;9(3):551-8.
1988: Peter Kenemans; C A Yedema; JH Hilgers; L F A G Massuger; René H M Verheijen; Chris M G Thomas; Lambert G Poels
Clinical applications of monoclonal antibodies against ovarian cancer-associated antigens.
European journal of obstetrics, gynecology, and reproductive biology 1988;29(3):207-18.
1988: C Yedema; L F A G Massuger; J Hilgers; J Servaas; Lambert G Poels; C Thomas; Peter Kenemans
Pre-operative discrimination between benign and malignant ovarian tumors using a combination of CA125 and CA15.3 serum assays.
International journal of cancer. Supplement = Journal international du cancer. Supplement 1988;3():61-7.